Gupta S K, Selvan V Kalai, Agrawal S S, Saxena Rohit
Delhi Institute of Pharmaceutical Sciences and Research, Sector 3, Pushp Vihar, New Delhi-110 017, India.
Indian J Ophthalmol. 2009 May-Jun;57(3):175-83. doi: 10.4103/0301-4738.49390.
Cataractous-opacification of the lens is one of the leading causes of blindness in India. The situation can be managed by surgical removal of the cataractous lens. Various pharmacological strategies have been proposed for the prevention and treatment of cataract. Information on possible benefits of putative anticataract agents comes from a variety of approaches, ranging from laboratory experiments, both in vitro and in vivo , to epidemiological studies in patients. This review deals with the various mechanisms, and possible pharmacological interventions for the prevention of cataract. The article also reviews research on potential anticataractous agents, including aldose reductase inhibitors, glutathione boosters, antiglycating agents, vitamins and various drugs from indigenous sources.
晶状体的白内障性混浊是印度失明的主要原因之一。这种情况可以通过手术摘除白内障晶状体来处理。已经提出了各种药理学策略用于白内障的预防和治疗。关于假定的抗白内障药物可能益处的信息来自多种途径,从体外和体内实验室实验到患者的流行病学研究。本综述探讨了预防白内障的各种机制以及可能的药理学干预措施。本文还综述了潜在抗白内障药物的研究,包括醛糖还原酶抑制剂、谷胱甘肽增强剂、抗糖化剂、维生素以及各种来自本土资源的药物。